ConductScience.org, home

Paper36924454

Clinicoserological insights into patients with immune checkpoint inhibitor-induced myasthenia gravis.

Masi G and 9 others. Ann Clin Transl Neurol, 2023. Cited by 22 papers, by iCite.

Cite this record

ConductScience Library. Clinicoserological insights into patients with immune checkpoint inhibitor-induced myasthenia gravis. Papers, record 36924454. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36924454

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinicoserological insights into patients with immune checkpoint inhibitor-induced myasthenia gravis.
PubMed
Journal
Ann Clin Transl Neurol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
1.91
iCite
Revised in PubMed
2026-09-28
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Masi GGianvitohttps://orcid.org/0000-0003-4754-2141
2Pham MCMinh Chttps://orcid.org/0000-0003-0234-4790
3Karatz TTabitha
4Oh SSangwookhttps://orcid.org/0000-0003-0092-9031
5Payne ASAimee Shttps://orcid.org/0000-0001-9389-7918
6Nowak RJRichard Jhttps://orcid.org/0000-0001-8438-482X
7Howard JF JrJames Fhttps://orcid.org/0000-0002-7136-8617
8Guptill JTJeffrey T
9Juel VCVern C
10O'Connor KCKevin Chttps://orcid.org/0000-0002-7056-419X

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Immune Checkpoint InhibitorsMajor topic
Myasthenia GravisMajor topic
Humans
Receptors, Cholinergic
Autoantibodies
Complement Activation

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
U2C TR002818NCATS NIH HHSUnited StatesU2CTR002818PubMed and NIHNIH RePORTER
R21 AI164590NIAID NIH HHSUnited StatesR21AI164590PubMed and NIHNIH RePORTER
UL1 TR001863NCATS NIH HHSUnited StatesUL1TR001863PubMedNIH RePORTER
R56 AI114780NIAID NIH HHSUnited StatesR01AI114780PubMed and NIHNIH RePORTER
R01 AI114780NIAID NIH HHSUnited StatesR01AI114780PubMed and NIHNIH RePORTER
U54 NS115054NINDS NIH HHSUnited StatesU54NS115054PubMed and NIHNIH RePORTER

Download CSV of grants

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135366559The clinical need for clustered AChR cell-based assay testing of seronegative MG.J Neuroimmunol2022https://conductscience.org/library/papers/35366559PubMed
29232426
Anti-acetylcholine receptor Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies.
Immunol Lett1997https://conductscience.org/library/papers/9232426PubMed
331753014Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature.J Immunother Cancer2019https://conductscience.org/library/papers/31753014PubMed
431217355Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients.JCI Insight2019https://conductscience.org/library/papers/31217355PubMed
536074148Receptor clustering and pathogenic complement activation in myasthenia gravis depend on synergy between antibodies with multiple subunit specificities.Acta Neuropathol2022https://conductscience.org/library/papers/36074148PubMed
621814823Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis.J Neurol2012https://conductscience.org/library/papers/21814823PubMed
734546336Encephalitis patient-derived monoclonal GABAA receptor antibodies cause epileptic seizures.J Exp Med2021https://conductscience.org/library/papers/34546336PubMed
831562797Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.N Engl J Med2019https://conductscience.org/library/papers/31562797PubMed
930185415
Pre-existing antiacetylcholine receptor autoantibodies and B cell lymphopaenia are associated with the development of myositis in patients with thymoma treated with avelumab, an immune checkpoint inhibitor targeting programmed death-ligand 1.
Ann Rheum Dis2019https://conductscience.org/library/papers/30185415PubMed
1034281989Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors.J Immunother Cancer2021https://conductscience.org/library/papers/34281989PubMed
1135473886Heterogeneity of Acetylcholine Receptor Autoantibody-Mediated Complement Activity in Patients With Myasthenia Gravis.Neurol Neuroimmunol Neuroinflamm2022https://conductscience.org/library/papers/35473886PubMed
1235065039Advances in the understanding of disease mechanisms of autoimmune neuromuscular junction disorders.Lancet Neurol2022https://conductscience.org/library/papers/35065039PubMed
1319890000Main immunogenic region structure promotes binding of conformation-dependent myasthenia gravis autoantibodies, nicotinic acetylcholine receptor conformation maturation, and agonist sensitivity.J Neurosci2009https://conductscience.org/library/papers/19890000PubMed
1433305263Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy.Brain Commun2020https://conductscience.org/library/papers/33305263PubMed
1535065040Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders.Lancet Neurol2022https://conductscience.org/library/papers/35065040PubMed
1633653902Neurologic Adverse Events of Immune Checkpoint Inhibitors: A Systematic Review.Neurology2021https://conductscience.org/library/papers/33653902PubMed
1732086972Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum.Ann Neurol2020https://conductscience.org/library/papers/32086972PubMed
1829931587Immune Checkpoint Inhibitors in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer.Curr Treat Options Oncol2018https://conductscience.org/library/papers/29931587PubMed
1929320654Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.N Engl J Med2018https://conductscience.org/library/papers/29320654PubMed

Download CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
42558562Editorial: Toward predictive and mechanistic approaches for precision neuroimmunotoxicology.Front Immunol2026https://conductscience.org/library/papers/42558562PubMed
41940097Case Report and literature review: immune checkpoint inhibitor-associated myasthenia gravis and myocarditis.Front Cardiovasc Med2026https://conductscience.org/library/papers/41940097PubMed
41835655Myasthenia-Like Presentations Following PD-1 Inhibitors: CD8+ Myositis, Myasthenia, or Both?Cureus2026https://conductscience.org/library/papers/41835655PubMed
41562147Pharmacovigilance Insights Into Immune Checkpoint Inhibitor-Induced Risk of Paraneoplastic Syndrome: A Large-Scale Real World Study.CNS Neurosci Ther2026https://conductscience.org/library/papers/41562147PubMed
41111929Neuromuscular complications associated with cancer immunotherapy.J Natl Cancer Cent2025https://conductscience.org/library/papers/41111929PubMed
40506552Complement activation profiles in patients with immune checkpoint inhibitor-associated neuromuscular immune-related adverse events.J Neurol2025https://conductscience.org/library/papers/40506552PubMed
40455120Immune checkpoint inhibitor-related myasthenia gravis, myocarditis and myositis: further insights.Support Care Cancer2025https://conductscience.org/library/papers/40455120PubMed
40246383Immune Checkpoint Inhibitor-Related Myocarditis With or Without Concomitant Myopathy: Clinical Findings and Cardiovascular Outcomes.JACC CardioOncol2025https://conductscience.org/library/papers/40246383PubMed
40181971Prediction, prevention, and precision treatment of immune checkpoint inhibitor neurological toxicity using autoantibodies, cytokines, and microbiota.Front Immunol2025https://conductscience.org/library/papers/40181971PubMed
39896961Features of myositis and myasthenia gravis in patients treated with immune checkpoint inhibitors: a multicentric, retrospective cohort study.Lancet Reg Health Eur2025https://conductscience.org/library/papers/39896961PubMed
39745587Eculizumab as rescue therapy for relapse of myasthenia gravis after immune-checkpoint inhibitors: a case report.Neurol Sci2025https://conductscience.org/library/papers/39745587PubMed
39514829Immune Checkpoint Inhibitor Myopathy: The Double-Edged Sword of Cancer Immunotherapy.Neurology2024https://conductscience.org/library/papers/39514829PubMed
39122934Peripheral nervous system immune-related adverse events due to checkpoint inhibition.Nat Rev Neurol2024https://conductscience.org/library/papers/39122934PubMed
38954314Clinical Issue of Myasthenia Gravis Related to Immune Checkpoint Inhibitors.Curr Oncol Rep2024https://conductscience.org/library/papers/38954314PubMed
37342323Immune-related adverse effects of checkpoint immunotherapy and implications for the treatment of patients with cancer and autoimmune diseases.Front Immunol2023https://conductscience.org/library/papers/37342323PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CMPK151727PubTator's text mininghttps://conductscience.org/library/genes/51727NCBI Gene
LRP44038PubTator's text mininghttps://conductscience.org/library/genes/4038NCBI Gene
MUSK4593PubTator's text mininghttps://conductscience.org/library/genes/4593NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36924454

GET https://conductscience.org/api/papers/v1/36924454/authors